Literature DB >> 18175176

Percutaneous radiofrequency ablation for treatment of recurrent retroperitoneal liposarcoma.

Sebastian Keil1, Philipp Bruners, Bernhard Brehmer, Andreas Horst Mahnken.   

Abstract

Percutaneous CT-guided radiofrequency ablation (RFA) is becoming more and more established in the treatment of various neoplasms, including retroperitoneal tumors of the kidneys and the adrenal glands. We report the case of RFA in a patient suffering from the third relapse of a retroperitoneal liposarcoma in the left psoas muscle. After repeated surgical resection and supportive radiation therapy of a primary retroperitoneal liposarcoma and two surgically treated recurrences, including replacement of the ureter by a fraction of the ileum, there was no option for further surgery. Thus, we considered RFA as the most suitable treatment option. Monopolar RFA was performed in a single session with a 2-cm umbrella-shaped LeVeen probe. During a 27-month follow-up period the patient remained free of tumor.

Entities:  

Mesh:

Year:  2008        PMID: 18175176     DOI: 10.1007/s00270-007-9263-7

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  7 in total

1.  Intraoperative radiofrequency ablation in an open thoracotomy setting for the new treatment of mediastinal liposarcoma: report of a case.

Authors:  Fumihiro Shoji; Akinobu Taketomi; Tokujiro Yano; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

2.  Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates.

Authors:  Koichiro Yamakado; Akihiko Matsumine; Tomoki Nakamura; Atsuhiro Nakatsuka; Haruyuki Takaki; Takao Matsubara; Kunihiro Asanuma; Akihiro Sudo; Yoshiki Sugimura; Hajime Sakuma
Journal:  Int J Clin Oncol       Date:  2013-11-28       Impact factor: 3.402

3.  CT-guided 125I seed implantation for inoperable retroperitoneal sarcoma: A technique for delivery of local tumor brachytherapy.

Authors:  Biao Yang; Wen-Hao Guo; Ting Lan; Fang Yuan; Guan-Jian Liu; Rui-Yu Zan; Xin You; Qiao-Yue Tan; Zheng-Yin Liao
Journal:  Exp Ther Med       Date:  2016-11-14       Impact factor: 2.447

4.  Feasibility and Efficacy of Microwave Ablation Combined with Iodine-125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical Experience.

Authors:  Mingjian Lu; Wang Yao; Tao Zhang; Wenzhe Fan; Zhihui Zhong; Jiaping Li; Fujun Zhang
Journal:  Oncologist       Date:  2017-07-12

5.  Percutaneous laser ablation: a new contribution to unresectable high-risk metastatic retroperitoneal lesions?

Authors:  Tian'an Jiang; Zhuang Deng; Guo Tian; Fen Chen; Haiwei Bao; Ju Li; Weilin Wang
Journal:  Oncotarget       Date:  2017-01-10

6.  US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: A care-compliant case report.

Authors:  Guo Tian; Tian'an Jiang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

7.  A systematic review of margin status in retroperitoneal liposarcomas: Does the R0 margin matter?

Authors:  Benjamin Paik; Chin Jin Seo; Joey Wee-Shan Tan; Wen Kai Darryl Juan; Khee Chee Soo; Chin-Ann Johnny Ong; Claramae Shulyn Chia; Jolene Si Min Wong
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.